While leading cytokine therapeutic developers are using next-generation cytokine engineering technologies to tackle enduring efficacy and toxicity challenges to take their molecules through the clinic, the field is also looking to novel targets, novel cytokines and an expanded disease focus.

As we enter a new era for cytokine therapies, armed with more cutting-edge technologies than ever before and enhanced translational understandings, the field is re-energizing the cytokine space to bring more life-changing drugs to patients.

Curating learnings from previous experiences, the 5th Cytokine-Based Drug Development Summit returns as the only industry dedicated cytokine meeting with a disease agnostic approach. The packed 3-day agenda will be addressing topics ranging from oncology to autoimmune and infectious diseases.

Time: 9:00 AM – 4:25 PM

Venue details: Wyndham Boston Beacon Hill, 5 Blossom Street, Boston, Massachusetts, 02114, United States

Prices: USD 2599.00 – USD 5097.00

Speakers: Aaron Meyer, Assistant Professor, UCLA, Audrey Le Floc’h, Associate Director, Regeneron, and more